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Accounting for about 1.5 million deaths annually, lung cancer is the prevailing cause of cancer deaths 
worldwide, mostly associated with long-term smoking effects. Numerous small-animal studies are 
performed currently in order to better understand the pathogenesis of the disease and to develop 
treatment strategies. Within this letter, we propose to exploit X-ray dark-field imaging as a novel 
diagnostic tool for the detection of lung cancer on projection radiographs. Here, we demonstrate in 
living mice bearing lung tumors, that X-ray dark-field radiography provides significantly improved lung 
tumor detection rates without increasing the number of false-positives, especially in the case of small 
and superimposed nodules, when compared to conventional absorption-based imaging. While this 
method still needs to be adapted to larger mammals and finally humans, the technique presented here 
can already serve as a valuable tool in evaluating novel lung cancer therapies, tested in mice and other 
small animal models.
With approximately 1.5 million deaths a year worldwide, lung cancer is the leading cause of cancer-induced 
deaths1, 2. Lung cancer is mostly diagnosed at an advanced stage with poor prognosis and has an average five-year 
survival rate of 15%3. The initial assessment of the lung in clinical routine is often done by conventional chest 
radiography, however, the sensitivity of detecting small nodules is particularly low. A recent study, for instance, 
demonstrated that the detection sensitivity drops below 50% for tumors with a mean size of 19 mm4. Further, the 
average size of missed lung nodules on a X-ray radiography is no less than 15 mm5. These results may explain 
why conventional x-ray chest radiography is not optimal as a mortality reducing screening program for (early) 
detection of lung cancer6.
In order to better understand the pathogenesis and develop treatment strategies numerous small-animal stud-
ies are currently being performed. In these studies, it is essential to be able to precisely detect and track the devel-
opment of lung nodules in vivo. Thus, it is possible to assess the impact of therapy over time. Currently, micro-CT 
and histology are used as the tools of choice for the lung nodule tracking. While histopathology offers an excellent 
opportunity, it is not suitable for longitudinal studies. Micro-CT can help localize the tumors, but it has a disad-
vantage of delivering quite a substantial dose to the animal. Accumulation of the dose can therefore bias or even 
falsify the results of the study7.
To address the aforementioned shortcomings, we propose to utilize the recently developed technique called 
X-ray dark-field radiography for the improved in-vivo assessment of lung cancer8, 9.
X-ray dark-field is a signal that quantifies the small-angle scattering that occurs in the lung at the air:tissue 
interfaces. Previous simulation10 and experimental results11–14 have demonstrated that changes to the size and 
number of the alveoli can be precisely detected with this imaging technique. Thus, recent studies with in vivo mice 
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demonstrated promising potential in detection of pulmonary disorders such as emphysema15, 16, and pulmonary 
fibrosis17, amongst others18, 19.
Thereby, the study by Hellbach et al.16 clearly revealed that the dark-field signal of the lung scales with the size 
of the alveoli, where in the publication by Yaroshenko et al.17 it was demonstrated that the signal also decreases 
with the decreasing number of alveoli. Here we show, using an in vivo small-animal lung cancer model (Fig. 1a) 
that x-ray dark-field contrast is also highly suitable for the detection of small tumor nodules which could be 
overlooked at the corresponding conventional image, by monitoring the cancer-caused reduction of the air:tissue 
volume ratio (Fig. 1b and c)20.
Finally, our study is highly significant for both clinical imaging and treatment development, providing a diag-
nostic and dose-saving framework for the assessment and evaluation of new lung cancer therapeutics and their 
application in mouse models.
Results
The detection of lung cancer using X-ray dark-field radiography was assessed in two steps. At first a qualitative 
radiographic investigation, using a transgenic animal model with spontaneous K-ras oncogene-driven growth of 
lung tumors which closely resembles human lung tumor development, was carried out. Subsequently, a quantita-
tive reader study was conducted, with experienced radiologists to compare detection rates of lung tumor nodules 
with dark-field versus conventional radiographs.
In-vivo dark-field radiography. Eight K-rasLA2 mutant mice and one wildtype control animal were imaged 
with a dose of 1.5 mGy using the small-animal scanner (acquisition parameters in Table 1)21. Corresponding 
absorption and dark-field radiograms of three typical animals with lung tumors and one control mouse are pre-
sented in Fig. 2. In case of “Mouse 1–3”, multiple lung tumors are clearly visible in H&E staining (bottom row), 
proving a successful introduction of cancer in the imaged animals. Due in part to the signal from structures 
Figure 1. Study design and background of in-vivo small-animal dark-field imaging of lung cancer. (a) As 
a disease model, K-rasLA2 mice were used. These mice frequently exhibit high-grade adenocarcinomas, 
developing from early onset lung adenomas. In-vivo dark-field imaging was performed using the Skyscan 
small-animal scanner, which is based on a Talbot-Lau interferometer. (b) X-ray dark-field imaging is highly 
sensitive to distortions of the natural lung micro-anatomy, as indicated using typical histopathology images: a 
pronounced air-tissue interface in healthy lung tissue (right) causes heavy X-ray scattering. In cancerous tissue 
(left) the air:tissue volume ratio is reduced due to uncontrolled cell proliferation and loss of alveolar space 
and therefore X-ray scattering is strongly reduced. Subsequently, information on the scatter properties of the 
lung can be retrieved by evaluating a setup-specific interference pattern. (c) Magnified histological sections 
visualise the impact of cancer on tissue density and a change in air:tissue distribution, respectively. The scale 
bar corresponds to 100 μm. This figure contains a lung illustration adapted from https://commons.wikimedia.
org/wiki/File:Diagram_1_of_3_showing_stage_3A_lung_cancer_CRUK_008.svg, which is licensed under the 
Attribution-ShareAlike 4.0 International license (http://creativecommons.org/licenses/by-sa/4.0/). Further a 
mouse sketch is adapted from https://commons.wikimedia.org/wiki/File:Knockout_mouse_breeding_scheme.
svg, which licensed under the Attribution 3.0 Unported license (http://creativecommons.org/licenses/by/3.0/). 
Both licenses allow adaptation of images, even commercially.
Source Voltage Tube Current Number of steps Exposure/step Total exposure Scan time Est. dose
35 kVp 0.57 mA 5 5 sec. 25 sec. 35 sec. 1.5 mGy
Table 1. Small-animal CT scanner acquisition parameters used for the in-vivo X-ray dark-field radiography 
lung cancer study.
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overlaying the lung, i.e. ribcage, heart shadow and the diaphragm, it is difficult to localize and differentiate these 
lung lesions on the transmission radiograms. Furthermore, small tumor lesions impose only minor variations to 
the overall optical density with respect to the surrounding healthy tissue, which renders an unambiguous detec-
tion of small nodules extremely challenging. In comparison, the impact of overlaying structures in dark-field 
imaging is much less severe, since signal arising from the lung – more precisely the alveoli – is dominant in 
the thorax region. This advantage enhances the assessment of lung lesions, since distortions in the homogene-
ous (strongly scattering) lung pattern are more easily perceived by the radiologist. Compared to the conven-
tional transmission signal, significantly more lung tumors (especially small nodules) are detectable and visible as 
(poorly scattering) black voids in the dark-field projections (as indicated by red arrows). In addition, the size and 
location of the tumors can be more clearly identified and were found to be in agreement with the histopatholog-
ical work-up.
Reader study: in-vivo dark-field radiography. In order to quantify the increase in diagnostic perfor-
mance gained through X-ray dark-field imaging, a reader study was conducted. Three experienced radiologists 
were blinded and both transmission and dark-field radiograms presented separately, with the option of scaling 
data-sets freely (for more details see Materials & Methods). To achieve a statistical relevance a total of 16 murine 
lungs (8 cancer-bearing; 8 healthy - 7 of these from a previous study17) were considered.
The number of detected tumors (true-positives) on transmission and dark-field images for the three readers 
are presented in Fig. 3, and demonstrate that dark-field imaging significantly outperforms transmission imaging 
with respect to the assessment of lung nodules, holding true for all three readers and each of the examined mice. 
We verified the here presented numbers by histology as method of reference. Note that we attribute the distinct 
inter-reader variance to the fact that the radiologists are trained in the evaluation of human radiographies and 
were not particularly trained for small-animal investigations. Compared to the transmission radiographs, we 
found an increase in tumor detection rates, ranging from at least 92% up to a maximum of 267%, when exploiting 
the dark-field channel. As a matter of fact, in the case of “Mouse 1” (see also Fig. 2) the lung was even rated as 
healthy on the transmission radiogram by all three radiologists, while 6, 6 and 9 small lesions were detected within 
the dark-field channel, respectively. Please note that we do not provide a percentage with respect to the overall 
number of tumors present within the lung, since an exact determination from histological work-up is ambiguous, 
especially in the case of very small tumors. Finally, our analysis further indicated that dark-field based diagnostics 
Figure 2. Qualitative benchmark of in-vivo transmission versus dark-field radiography for the assessment of 
lung nodules. Typical transmission and dark-field radiograms of a control mouse and three mice with lung 
tumors, alongside with the corresponding histological sections in H&E staining. Small nodules are much easier 
to detect within the dark-field image (red arrows) than in the attenuation channel, due to a minor impact of 
overlaying structures and the overall dominant scatter signal of the lung within the thorax. The scale bars 
correspond to 5 mm and 2.5 mm on the radiograms and histological sections, respectively. The color-scale 
corresponds to the linear signal of both dark-field and transmission images.
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increase the diagnostic specificity of lung tumor assessment, by reducing the number of false-positives within the 
control group of healthy mice from an overall of 6 to 4 incidences (see also Fig. 3 - bottom).
Exceeding these insights, the reader study further indicated that scatter-based imaging enables a better 
determination not only of tumor numbers but also shape, size and delineation. This observation is illustrated in 
Fig. 4, where one of the readers digitally evaluated/sketched the extensions for each of the detected lung nodules. 
Photographs of the freshly excised lungs were utilized for reference. In case of “Mouse 2” for instance, two sepa-
rated lesions were originally assumed, based on the transmission signal, in the bottom of the left lung. Evaluating 
the dark-field signal it is apparent that only one large tumor is present. In case of “Mouse 3”, the nodule in the 
right was estimated as round by the radiologist, while an oval tumor shape was found in the dark-field channel, in 
agreement with the photograph and pathology.
Nevertheless, Fig. 4 also gives evidence that dark-field radiography is not yet capable of resolving all tum-
ors, as indicated by black circles in the photograph. This is due to the planar nature of a radiographic imaging 
mode, where very small tumors can potentially be superimposed by other large tumors or the prominent signal of 
healthy tissue. The largest missed tumor was estimated from histology and measured with a diameter of 0.7 mm.
Hence, in order to evaluate the potential of X-ray dark-field imaging in the assessment of superimposed or 
very small tumors, we are currently extending our study to tomographic investigations of living mice.
Discussion
Within this study, we presented the very first dose-compatible in-vivo dark-field measurements of mice with lung 
cancer and found a superior diagnostic performance compared to conventional radiography. Thereby, we verified 
two main advantages associated with the dark-field signal: first, structures overlying the lung are weakly scattering 
and thereby do not influence the visibility of the lung. Second, micro-structural differences between healthy and 
cancerous lung tissue provide intrinsically enhanced scatter contrast.
While these results are very promising, we have to consider that within this proof-of-principle (reader) study 
none of the lately developed ribcage suppression algorithms had been applied22–25. Although these are yet not 
applied in daily clinical routine, they yield the potential to increase the quality of lung nodule visualization in 
transmission radiography as such22, 25, 26. In addition, in translating our findings to clinical imaging, it is uncer-
tain to which degree scatter caused by the human ribcage and spine will corrupt the visibility of the human lung. 
Therefore, future studies will have to consider the aforementioned algorithms for transmission radiographies to 
provide a fair comparison. However, a very initial benchmark (Fig. 5) following the method described by von 
Berg et al. suggests that the inherent micro-structural sensitivity of dark-field imaging strongly outweighs the 
diagnostic benefits arising from ribcage suppression/correction algorithms only25: while one small nodule in 
the left upper lung (green box) does indeed become detectable in the transmission image after removing the 
ribcage, another tumor in the upper right lung (blue box) remains hidden in the transmission signal throughout 
rib-removal, and is reliably detected in the darkfield channel only.
Figure 3. Reader study: transmission versus dark-field radiography in-vivo. Based on the transmission 
and dark-field radiograms, three experienced and blinded radiologists were asked to assess the number of 
radiopaque tumors in 16 mice (8 tumor-bearing, 8 healthy). A significant improvement in detection rate (true-
positives) was found, when exploiting scatter-sensitive dark-field imaging, ranging from an average increase by 
92% up to a maximum increase of 267%. Based on the control group our analysis provided evidence, that dark-
field radiography additionally enhances diagnostic specificity, by reducing the number of false-positives from an 
overall of 6 to 4 incidences.
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Figure 4. Improved assessment of tumor size, shape and delineation using X-ray dark-field radiography. 
Transmission and dark-field radiograms of two mice with lung cancer are taken from Fig. 2 and evaluated by 
a blinded reader. The green ellipses indicate tumors, which were correctly assessed in both imaging channels. 
The red ellipses indicate tumors which were detected in the transmission image, but misjudged with respect to 
size or shape, e.g. being mistakenly classified as separated (Mouse 2) or round (Mouse 3). Blue ellipses account 
for tumors which were correctly assessed within the dark-field radiogram only. Overlooked/missed tumors are 
indicated on the photograph by black ellipses.
Figure 5. Outlook: initial comparison of ribcage-corrected transmission versus dark-field radiography and 
impact on tumor detection quality. In the left upper lung (green box) a small nodule is superimposed by 
multiple ribs and is visible only after ribcage removal, as indicated by a white circle in the filtered transmission 
radiogram. In case of a small lesion in the upper right (blue box), however, the tumor provides insufficient 
contrast with respect to healthy tissue, rather then being superimposed by bones. Consequently the suppression 
algorithm is not altering the detectability of the tumor. Note that both tumors are easily visible in the 
dark-field channel (white circles), contingent on a strongly enhanced sensitivity towards distortions in the 
micromorphological lung pattern caused by cancerous tissue. The scale bar corresponds to 5 mm.
www.nature.com/scientificreports/
6Scientific RepoRts | 7: 402  | DOI:10.1038/s41598-017-00489-x
Further, we hypothesize that the distinct sensitivity towards pathological changes in the pulmonary micro-
morphology may be of special interest for the detection of non-solid growing tumors, which are typically radi-
olucent in conventional radiography in early stages. Here, the tumor slowly proliferates along the alveolar walls 
reducing the amount of incorporated air and therewith scattering surface, while not significantly changing the 
optical density of related tissue20.
In general, X-ray dark-field imaging requires at least a doubling of dose, due to the presence of an absorber 
grating. We would like to point out that if a transmission image was acquired with the dose required for x-ray 
dark-field radiography, its SNR would have been better. However, a factor of two in dose results only in a slight 
increase of the SNR by a factor of = .(2) 1 4. Finally, in conventional radiography systems there is an anti-scatter 
grid behind the sample (which also reduces the flux by approx. 20%), further reducing the difference in SNR 
between the attenuation images taken with a GI and the images taken with a conventional system. Therefore, we 
believe the presence of the GI in the imaging system does not influence the quality of the transmission images 
significantly. Similar imaging results have been previously reported27.
The mice were breathing freely during the image acquisition. As no gating was applied, this introduced some 
blurring to the images. However, given the typical motion amplitude of the murine lung in the range28 of 200 μm 
and the resolution of the system29 of approximately 70 μm, the motion artifacts have been found to be negligible in 
the past30. Therefore, the deviation of the actual tumor size from the estimated one is considered to be negligible.
Our results indicate that x-ray dark-field radiography is a promising candidate for both lung cancer screening 
and monitoring high-risk human patients, offering a significantly increased cancer detection rate (true-positives), 
without increasing the rate of false-positives. A fusion of the simultaneously acquired transmission and dark-field 
signal would further provide the radiologist with anatomical and scatter-sensitive (functional) imaging at a single 
glance. However, before this technology can be adapted to human imaging, several technical challenges have to be 
addressed. Experiments presented here were carried out at 35 kVp, whereas for human imaging, energies between 
80–120 kVp are typically used. In general, feasibility of x-ray dark-field imaging has been demonstrated for such 
high energies31–33. These studies have also demonstrated that while Compton Scattering increases for higher x-ray 
energies, the G2 grating acts as an anti-scatter grating and allows thus for signal extraction. However, in general 
the visibility in a grating interferometer is typically reduced by a broad x-ray spectrum. Therefore, future studies 
should consider how the x-ray spectrum should be shaped to obtain the optimal quality for human imaging. 
Furthermore, the field of view has to be strongly increased. At the moment, it is limited by the size of the available 
gratings. Recently, several studies have reported the possibility of stitching several gratings together in order to 
increase the size of the field of view34. Tiling of the gratings as reported in the literature would allow to construct 
a field of view suitable for human chest imaging, and combined with a powerful enough x-ray source this would 
make it possible to acquire human chest radiograms with acquisition times below 1 second. Finally, the design 
of the grating interferometer for human imaging has to be carefully considered. On one the hand, the scattering 
signal obtained at e.g. 120 kVp would be significantly less than at 35 kVp, but on the other hand, the human lung 
is much thicker, so the signal strength should be much higher. Finally, the size of the human alveoli35 is approx. 
200 μm, whereas those of mice are approx. 60 μm in diameter28. Therefore, the dark-field signal from human lungs 
will be weaker as described in theoretical studies36–38. All these effects have to be carefully considered for the 
design of an interferometer for human imaging. However, the sensitivity of the interferometer can be adjusted by 
adapting the grating periods and grating shape36–41. In general, for human lungs we can expect an increase in the 
alveoli size by a factor of approximately 3–4, which requires a smaller grating pitch by a factor of 3–4 to obtain the 
same signal strength for the object of the same sample thickness. However, a human lung is thicker than a murine 
one approximately by a factor of 10. Therefore, even if the mean energy is increased by a factor of 2, it can be 
assumed that the grating periods can be slightly larger for imaging of human lungs causing a slight increase in the 
system length. A total length of approximately 2 meters seems reasonable, which corresponds to the length of the 
typical system currently used for clinical radiography. To further investigate this issue, we are currently extending 
our investigations to larger animals, in order to model and estimate the performance of dark-field imaging for 
humans and disprove concerns with respect to beam hardening or patient variability.
The proposed technique is already a valuable tool for validation of novel therapeutic strategies, allowing for 
non-invasive monitoring in (dose-sensitive) small-animal lung cancer experiments. Currently, only micro-CT 
is utilized to this end detect lung tumors in mice, applying doses of 170–280 mGy per scan7. Here, concerns 
arise with respect to adverse radiation-induced side effects which may falsify the outcome of long-term studies7. 
Conventional x-ray radiography has not been used in small-animal experiments due to the lack in sensitivity. 
Based on our data, x-ray radiography could represent a superior imaging modality. Compared to the conventional 
radiography, x-ray radiography has a much higher sensitivity, and compared to the conventional micro-CT, it 
requires significantly less radiation dose at the cost of volumetric information.
As the proof of concept data presented here are merely qualitative, future work should focus on quantitative 
analysis of these findings. Dark-field CT can be employed to allow for quantitative comparison of transmission 
versus dark-field signal to validate the superiority of x-ray dark-field imaging with respect to the conventional 
radiography42. These are the first proof of concept findings on mice with heterogeneous tumor load and further 
studies have to be carried out in order to validate the minimum size of the nodules that can be reliably detected 
with x-ray dark-field radiography.
Materials and Methods
Ethics statement. Animal experiments were performed with permission of the Institutional Animal Care 
and Use Committee of the Helmholtz Zentrum Munich and carried out in accordance with national (Gesellschaft 
für Versuchstierkunde - Society for Laboratory Animal Science) and international (Federation for Laboratory 
Animal Science Associations) animal welfare guidelines. All experimental protocols were approved by the 
Institutional Animal Care and Use Committee of the Helmholtz Zentrum Munich.
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Small-animal lung cancer model and animal handling. For this study, 129 S/Sv-Krastm3Tyj/J (K-rasLA2) 
mutant mice (Jackson Laboratory, Maine, USA) were used. In this mouse model, somatic activation of a latent 
K-ras allele with a G12D mutation at codon 12 leads to spontaneous development of early onset lung adenomas 
with 100% penetrance, that eventually evolve to high-grade adenocarcinomas43. K-ras mutation is predominantly 
seen in patients with non-small-cell lung cancer accounting for 20–30% of all incidences44.
Mice were anesthetized using intraperitoneal injection of medetomidine (500 μg/kg), midazolam (5 mg/kg), 
and fentanyl (50 μg/kg) during imaging and sacrificed after imaging with an overdose of ketamine and xylazin 
hydrochloride solution (bela-pharm, Germany). The mice were breathing freely during the image acquisition.
Small-animal scanner. The imaging was performed using a small-animal scanner21, 45. The design of the 
scanner was optimized for murine lung imaging in a number of steps. After initial simulations46, the signal of 
the ex vivo lung was validated11, 12 before the interferometer was used to image an in vivo mouse47. Subsequently, 
the signal decay was validated in good agreement with simulations and micro-bubbles10, 13 and mouse mod-
els of emphysematous15, 16 and fibrotic tissue17. In addition to the conventional X-ray gantry, consisting of an 
X-ray source (fixed anode tungsten-target MCBM 65B-50 W tube (RTW, Neuenhagen, Germany)) and a flatpanel 
(C9312SK-06 Hamamatsu (Hamamatsu, Japan)) detector with a GOS scintillator and 50 μm pixel size, a three 
grating Talbot-Lau interferometer was introduced. The interferometer consists of a source grating (G0) with a 
period of 10 μm and gold height of 35 μm, a binary phase grating (G1) that has a period of 3.24 μm and a nickel 
height of 4 μm and, finally, an analyzer grating with a period of 4.8 μm and 45 μm high gold bars. The design 
energy of the system is 23 keV. The distances between the source, the phase grating and the analyzer grating are 30 
and 14.5 cm respectively, and the interferometer is operated in the first fractional Talbot order. A piezo positioner 
is used to move the source grating in order to acquire the phase stepping curve48. A sample bed is used to position 
the sample right in front of the phase grating. The scanner is equipped with breath and heart rate monitoring sys-
tem and a warm air fan to keep the animals temperature constant during in vivo imaging. Besides the attenuation 
and dark-field images, the scanner also provides the differential phase contrast images. However, these images are 
not included in this study and are only presented in supplementary Figure 1 for the interested reader.
Reader-study. A blinded reader study was performed with three radiologists (four years of professional 
experience), who were familiar with the concept of X-ray dark-field imaging. The evaluation of the randomized 
transmission and dark-field images was performed separately with a certain temporal interval so that a recall bias 
was avoided, e.g. the readers could not build on the previous results. All readers were allowed to freely adjust the 
windowing and the magnification of the images using OsiriX Dicom Viewer (Pixmeo Sarl, Bernex, Switzerland). 
The readers were asked to mark lung cancer and delineate the boundaries of lung nodules.
Histological preparations. Following intubation of the mice and diaphragm dissection, airways were 
inflated with 4% (w/v) paraformaldehyde (PFA). Later, the tracheae were knotted, the lungs were excised and 
transferred into 4% PFA-loaded tubes for tissue fixation overnight at 46 °C. After tissue processing and paraffin 
embedding, 3 μm thick sections were cut and placed on SuperfrostTM Plus Adhesion Slides (Thermo Scientific). 
The de-paraffinized sections were stained with hematoxylin and eosin (Carl Roth, Germany) subsequently, and 
dehydrated respectively in consecutively grading ethanol and xylene solutions (AppliChem, Germany). Dried 
sections were mounted with entellan (Merck, Germany).
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